You need adobe flash player to view this content

Top Stories

Phil Baumann outlines why the pharma industry needs to submerge itself into the binary world of social media.

As the social media revolution continues its surge of success in the realms of digital marketing and communications, Nick Pryke takes a look at why sailing into the eye of its storm could be the best thing for the pharma...

Casting a wider net

How Eli Lilly’s towards a networking structure could serve them well at the innovation table.

H1N1 pandemic: 'unjustified scare' and was...

The handling of the H1N1 pandemic by the World Health Organization (WHO), along with European Union agencies and national governments, resulted in a "waste of large sums of public money, and unjustified scares and fears...

The emerging pharmaceutical markets

Emerging markets look set to catch up to the Western world in healthcare standards. Jesper Høiland outlines the pharmaceutical industry’s response.

More Like This

Latest News

Top 10 Pharma Layoffs of 2010

Top 10 Pharma Layoffs of 2010
17/02/2011 16:45
Read more
Comments
CureFAKtor Pharmaceuticals Receives Orph...

CureFAKtor Pharmaceuticals, LLC, a privately-held biopharmaceutical company focused on the research and development of Focal Adhesion Kinase (FAK) inhibitors for cancer, today...
19/01/2011 10:31
Read more
Comments
Pharma to See Big Growth in East in 2011

According to investment international, 2011 will be a successful year for the pharmaceutical industry due to a rise in emerging markets, which is estimated to grow by 70 percent...
05/01/2011 14:19
Read more
Comments
Neovacs: Crohn's Disease Immunotherapy T...

Neovacs, a biotechnology company focused on active immunotherapy for autoimmune and inflammatory diseases and cancer, today announced the final results of its Phase I/II...
09/12/2010 08:49
Read more
Comments
Aspirin Reduces Cancer Risk by 21%

British researchers revealed in an article published in The Lancet that a daily dose in the range of 75mg to 500mg of Aspirin reduced the risk of cancer by 21 percent. In most...
07/12/2010 16:48
Read more
Comments
Ian Read to Replace Jeffrey Kindler as P...

Pfizer, the world's largest pharmaceutical company has announced that CEO Jeffrey Kindler has retired, paving the way for global biopharmaceutical operations, Ian Read, as his...
07/12/2010 14:34
Read more
Comments

More Like This

Editor’s Choice

Joe Jimenez: Setting a new course

NGP speaks to Joe Jimenez about life as a CEO and his plans for the future of the Novartis.
Read more
H1N1 pandemic: 'unjustified scare' and waste of...

The handling of the H1N1 pandemic by the World Health Organization (WHO), along with European Union agencies and national governments, resulted in a "waste of large sums of...
Read more
The force is with you

With patent expiries and generic competition on the rise, the pharmaceutical industry is being scrutinised like never before. As a result, sales force effectiveness is taking...
Read more
All change

Raafat Fahim of Nabi Biopharmaceuticals explains why a new, more efficient business model is needed to cope with the increasing challenges facing the industry.
Read more
Hunting down cancer

Tumours continue bypassing cell pathways whilst molecular biologists doggedly try to understand how cancer works. Haren Rupani explains why we are still in our infancy of cancer...
Read more
Getting personal

William Chin tells Natalie Brandweiner how Lilly is using tailored therapeutics to improve outcomes for patients and boost its bottom line.
Read more

More Like This

Readers’ Choice

Process excellence in master data manage...

It makes sense to analyze and ensure that the foundations of master data governance are solid and provide the business with strong processes to manage and share master data...
Read more
End-to-end clinical trials supply manage...

Stakeholders point to the clinical costs as a barrier to innovation. The FDA has confirmed in its “Critical path report” that “Streamlining Clinical Trials” is one of the key...
Read more
Imaging is key to success in oncology tr...

As defined by the NCI, "Translational research transforms scientific discoveries arising from laboratory, clinical, or population studies into clinical applications to reduce...
Read more
Emerging importance of health economics ...

Jacco Keja, Managing Director and Practice Leader at Quintiles Consulting, Visiting Professor Life Sciences Pricing, Erasmus University, looks at the emerging opportunities for...
Read more
Riding the wave

The global pharmaceutical industry is facing some tough challenges at the moment: patent expiries, a lack of new blockbusters, and now the ongoing crisis in the financial...
Read more
Building a sustainable biotech business ...

By Willem van Leeuwen – Managing Director QMR Technology
Read more